Hypertension prevalence in the All of Us Research Program among groups traditionally underrepresented in medical research

被引:7
作者
Chandler, Paulette D. [1 ]
Clark, Cheryl R. [1 ]
Zhou, Guohai [1 ]
Noel, Nyia L. [2 ]
Achilike, Confidence [2 ]
Mendez, Lizette [2 ]
Ramirez, Andrea H. [3 ]
Loperena-Cortes, Roxana [3 ]
Mayo, Kelsey [3 ]
Cohn, Elizabeth [4 ]
Ohno-Machado, Lucila [5 ]
Boerwinkle, Eric [6 ]
Cicek, Mine [7 ]
Qian, Jun [3 ]
Schully, Sheri [8 ]
Ratsimbazafy, Francis [3 ]
Mockrin, Stephen [9 ]
Gebo, Kelly [10 ]
Dedier, Julien J. [2 ]
Murphy, Shawn N. [11 ]
Smoller, Jordan W. [12 ]
Karlson, Elizabeth W. [1 ]
机构
[1] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA 02115 USA
[2] Boston Univ, Sch Med, Boston Med Ctr, Boston, MA 02118 USA
[3] Vanderbilt Univ, Med Ctr, Nashville, TN USA
[4] CUNY Hunter Coll, New York, NY 10021 USA
[5] Univ Calif San Diego, San Diego, CA 92103 USA
[6] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Houston, TX 77030 USA
[7] Mayo Clin, Rochester, MN USA
[8] NIH, Bldg 10, Bethesda, MD 20892 USA
[9] Leidos Inc, Life Sci Div, Frederick, MD USA
[10] Johns Hopkins Univ, Baltimore, MD USA
[11] Mass Gen Brigham, Res Informat Sci & Comp, Boston, MA USA
[12] Massachusetts Gen Hosp, Ctr Genom Med, Boston, MA 02114 USA
基金
美国国家卫生研究院;
关键词
BLOOD-PRESSURE; HEALTH; DEFINITIONS; DISEASE;
D O I
10.1038/s41598-021-92143-w
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The All of Us Research Program was designed to enable broad-based precision medicine research in a cohort of unprecedented scale and diversity. Hypertension (HTN) is a major public health concern. The validity of HTN data and definition of hypertension cases in the All of Us (AoU) Research Program for use in rule-based algorithms is unknown. In this cross-sectional, population-based study, we compare HTN prevalence in the AoU Research Program to HTN prevalence in the 2015-2016 National Health and Nutrition Examination Survey (NHANES). We used AoU baseline data from patient (age >= 18) measurements (PM), surveys, and electronic health record (EHR) blood pressure measurements. We retrospectively examined the prevalence of HTN in the EHR cohort using Systemized Nomenclature of Medicine (SNOMED) codes and blood pressure medications recorded in the EHR. We defined HTN as the participant having at least 2 HTN diagnosis/billing codes on separate dates in the EHR data AND at least one HTN medication. We calculated an age-standardized HTN prevalence according to the age distribution of the U.S. Census, using 3 groups (18-39, 40-59,and >= 60). Among the 185,770 participants enrolled in the AoU Cohort (mean age at enrollment=51.2 years) available in a Researcher Workbench as of October 2019, EHR data was available for at least one SNOMED code from 112,805 participants, medications for 104,230 participants, and 103,490 participants had both medication and SNOMED data. The total number of persons with SNOMED codes on at least two distinct dates and at least one antihypertensive medication was 33,310 for a crude prevalence of HTN of 32.2%. AoU age-adjusted HTN prevalence was 27.9% using 3 groups compared to 29.6% in NHANES. The AoU cohort is a growing source of diverse longitudinal data to study hypertension nationwide and develop precision rule-based algorithms for use in hypertension treatment and prevention research. The prevalence of hypertension in this cohort is similar to that in prior population-based surveys.
引用
收藏
页数:10
相关论文
共 33 条
[1]   The "All of Us" Research Program [J].
Denny J.C. ;
Rutter J.L. ;
Goldstein D.B. ;
Philippakis A. ;
Smoller J.W. ;
Jenkins G. ;
Dishman E. .
NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (07) :668-676
[2]  
Appel LJ, 2003, JAMA-J AM MED ASSOC, V289, P2083, DOI 10.1001/jama.289.16.2083
[3]   A clinical trial of the effects of dietary patterns on blood pressure [J].
Appel, LJ ;
Moore, TJ ;
Obarzanek, E ;
Vollmer, WM ;
Svetkey, LP ;
Sacks, FM ;
Bray, GA ;
Vogt, TM ;
Cutler, JA ;
Windhauser, MM ;
Lin, PH ;
Karanja, N .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (16) :1117-1124
[4]  
Benjamin E. J., 2018, CIRCULATION, V137, P67, DOI [DOI 10.1161/CIR.0000000000000573, 10.1161/CIR.0000000000000558]
[5]   Prospects for the Primary Prevention of Myocardial Infarction and Stroke [J].
Caldwell, Madison ;
Martinez, Lisa ;
Foster, Jennifer G. ;
Sherling, Dawn ;
Hennekens, Charles H. .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2019, 24 (03) :207-214
[6]  
Chaikijurajai T, 2020, AM J HYPERTENS
[7]   National Surveillance Definitions for Hypertension Prevalence and Control Among Adults [J].
Crim, Matthew T. ;
Yoon, Sung Sug ;
Ortiz, Eduardo ;
Wall, Hilary K. ;
Schober, Susan ;
Gillespie, Cathleen ;
Sorlie, Paul ;
Keenan, Nora ;
Labarthe, Darwin ;
Hong, Yuling .
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2012, 5 (03) :343-351
[8]   Genome-wide study of resistant hypertension identified from electronic health records [J].
Dumitrescu, Logan ;
Ritchie, Marylyn D. ;
Denny, Joshua C. ;
El Rouby, Nihal M. ;
McDonough, Caitrin W. ;
Bradford, Yuki ;
Ramirez, Andrea H. ;
Bielinski, Suzette J. ;
Basford, Melissa A. ;
Chai, High Seng ;
Peissig, Peggy ;
Carrell, David ;
Pathak, Jyotishman ;
Rasmussen, Luke V. ;
Wang, Xiaoming ;
Pacheco, Jennifer A. ;
Kho, Abel N. ;
Hayes, M. Geoffrey ;
Matsumoto, Martha ;
Smith, Maureen E. ;
Li, Rongling ;
Cooper-DeHoff, Rhonda M. ;
Kullo, Iftikhar J. ;
Chute, Christopher G. ;
Chisholm, Rex L. ;
Jarvik, Gail P. ;
Larson, Eric B. ;
Carey, David ;
McCarty, Catherine A. ;
Williams, Marc S. ;
Roden, Dan M. ;
Bottinger, Erwin ;
Johnson, Julie A. ;
de Andrade, Mariza ;
Crawford, Dana C. .
PLOS ONE, 2017, 12 (02)
[9]  
Fryar Cheryl D, 2017, NCHS Data Brief, P1
[10]   Effectiveness of chlorthalidone/amiloride versus losartan in patients with stage I hypertension and diabetes mellitus: results from the PREVER-treatment randomized controlled trial [J].
Fuchs, Flavio D. ;
Scala, Luiz C. N. ;
Vilela-Martin, Jose F. ;
Whelton, Paul K. ;
Poli-de-Figueiredo, Carlos E. ;
Silva, Ricardo ;
Gus, Miguel ;
Bortolotto, Luiz A. ;
Consolim-Colombo, Fernanda M. ;
Schlatter, Rosane P. ;
Cesarino, Jose E. ;
Castro, Iran ;
Figueiredo Neto, Jose A. ;
Chaves, Hilton ;
Steffens, Andre A. ;
Alves, Joao G. ;
Brandao, Andrea A. ;
de Sousa, Marcos R. ;
Jardim, Paulo C. ;
Moreira, Leila B. ;
Franco, Roberto S. ;
Gomes, Marco M. ;
Afiune Neto, Abrahao ;
Fuchs, Felipe C. ;
Sobral Filho, Dario C. ;
Nobrega, Antonio C. ;
Nobre, Fernando ;
Berwanger, Otavio ;
Fuchs, Sandra C. .
ACTA DIABETOLOGICA, 2021, 58 (02) :215-220